Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC Lunit's AI solution is the first application in Guardant Galaxy, a suite of AI and other...

Lunit to present five posters at ESMO 2022 featuring the company's AI-biomarker platform Studies corroborate the capability of Lunit SCOPE suite to address an expanding set of clinical and research questions based on world-leading...

Phillipsburg, NJ- January 12, 2022 – INFINITT North America, an award-winning developer of enterprise imaging solutions for healthcare, today announced a partnership to market Lunit AI software, making it readily available to its North...